Guidelines; Telemetry Data For Europe - BIOTRONIK CardioMessenger Smart Manual Tecnico

8 Guidelines

Telemetry Data for Europe

Your implanted device transmits diagnostic data
to the CardioMessenger via a radio frequency
(RF) assigned by the European Conference of
Postal and Telecommunications Administration
for the operation of Ultra Low Power Active
Medical Implants (CEPT/ERC REC 70-03).
BIOTRONIK is legally obligated to inform you that
the radio service does not have exclusive use of
the assigned frequencies and that the
transmission of device data is not permitted to
interfere with other radio services. The frequency
and technical parameters of the built-in
transmitter have been carefully selected to
ensure that electromagnetic interference
between other services and the data
transmission of the device is unlikely.
Furthermore, BIOTRONIK is obligated to inform
you that the regulatory agency can withdraw the
frequency allocation and prohibit the radio
service between the device and
CardioMessenger. Since this service is currently
established throughout Europe and North
America, withdrawal of the frequency allocation
is not expected in the foreseeable future.
en • English
Guidelines
33